Javascript must be enabled to continue!
Immunotherapy and Biopharmaceuticals
View through CrossRef
For thousands of years, plants have played a vital role in medicine, with an
estimated 80% of the global population relying on herbal remedies for healthcare,
particularly in regions with limited access to conventional pharmaceuticals. Among
these medicinal plants, garlic (Allium sativum L.) has gained significant attention due
to its potent bioactive compound allicin. Allicin is enzymatically produced when garlic
is crushed, converting the precursor alliin into this sulfur-containing compound. It
exhibits a broad spectrum of health-promoting properties, including antimicrobial,
anticancer, antioxidant, and cardiovascular protective effects. Recent studies have also
highlighted allicin’s immunomodulatory potential, suggesting a possible role in
immunotherapy, particularly in enhancing the immune system's ability to detect and
combat disease. Immunotherapy, a cutting-edge approach in oncology, leverages the
body’s own immune system to target and eliminate cancer cells. It has become a major
focus of global cancer research. For instance, a recent large-scale study compared
neoadjuvant and adjuvant immunotherapy in perioperative cancer patients,
underscoring the growing significance of immunotherapy in clinical settings. Despite
allicin's therapeutic promise, especially in immunomodulation, several challenges
hinder its broader application. These include a limited understanding of its precise
mechanisms of action, instability during processing, and variability in yield depending
on the extraction method. This chapter addresses these issues through a comprehensive
bioprospecting approach that integrates molecular docking techniques to investigate
allicin’s interactions with bacterial proteins and drug resistance targets. Moreover, the
study evaluates eco-friendly and efficient extraction techniques, including the use of
green solvents and ultrasound-assisted extraction, to enhance allicin yield and stability.
By combining innovative extraction methodologies with molecular and
pharmacological insights, this chapter aims to promote the therapeutic application of
allicin, particularly in the emerging field of immunotherapy, thereby contributing to the
development of effective, natural, and sustainable biopharmaceuticals.
BENTHAM SCIENCE PUBLISHERS
Title: Immunotherapy and Biopharmaceuticals
Description:
For thousands of years, plants have played a vital role in medicine, with an
estimated 80% of the global population relying on herbal remedies for healthcare,
particularly in regions with limited access to conventional pharmaceuticals.
Among
these medicinal plants, garlic (Allium sativum L.
) has gained significant attention due
to its potent bioactive compound allicin.
Allicin is enzymatically produced when garlic
is crushed, converting the precursor alliin into this sulfur-containing compound.
It
exhibits a broad spectrum of health-promoting properties, including antimicrobial,
anticancer, antioxidant, and cardiovascular protective effects.
Recent studies have also
highlighted allicin’s immunomodulatory potential, suggesting a possible role in
immunotherapy, particularly in enhancing the immune system's ability to detect and
combat disease.
Immunotherapy, a cutting-edge approach in oncology, leverages the
body’s own immune system to target and eliminate cancer cells.
It has become a major
focus of global cancer research.
For instance, a recent large-scale study compared
neoadjuvant and adjuvant immunotherapy in perioperative cancer patients,
underscoring the growing significance of immunotherapy in clinical settings.
Despite
allicin's therapeutic promise, especially in immunomodulation, several challenges
hinder its broader application.
These include a limited understanding of its precise
mechanisms of action, instability during processing, and variability in yield depending
on the extraction method.
This chapter addresses these issues through a comprehensive
bioprospecting approach that integrates molecular docking techniques to investigate
allicin’s interactions with bacterial proteins and drug resistance targets.
Moreover, the
study evaluates eco-friendly and efficient extraction techniques, including the use of
green solvents and ultrasound-assisted extraction, to enhance allicin yield and stability.
By combining innovative extraction methodologies with molecular and
pharmacological insights, this chapter aims to promote the therapeutic application of
allicin, particularly in the emerging field of immunotherapy, thereby contributing to the
development of effective, natural, and sustainable biopharmaceuticals.
Related Results
Biopharmaceuticals—Current Information and New Challenges
Biopharmaceuticals—Current Information and New Challenges
Biopharmaceuticals are medical drugs produced by means of biotechnology. In contrast with small-molecule (traditional) drugs, which are usually synthesized chemically, biopharmaceu...
What are biopharmaceuticals?
What are biopharmaceuticals?
Throughout history, biopharmaceuticals have been essential in addressing health crises and enhancing human well-being. With advancements in genetic engineering, biotechnology, and ...
Progress in biopharmaceutical development
Progress in biopharmaceutical development
AbstractSince its introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases and are increasingly used in nearly all branches o...
Biopharmaceuticals: A review of their development and contribution to healthcare
Biopharmaceuticals: A review of their development and contribution to healthcare
Biopharmaceuticals play a crucial role in preventing, treating, and diagnosing a diverse range of diseases across various medical disciplines. The market for biopharmaceuticals has...
Pharmaceutical and Biopharmaceuticals Industries: Revolutionizing Healthcare
Pharmaceutical and Biopharmaceuticals Industries: Revolutionizing Healthcare
The pharmaceutical and biopharmaceuticals industries play a crucial role in revolutionizing healthcare by developing and delivering innovative medicines and therapies. These indust...
Pathological response following neoadjuvant immunotherapy and imaging characteristics in dMMR/MSI-H locally advanced colorectal cancer
Pathological response following neoadjuvant immunotherapy and imaging characteristics in dMMR/MSI-H locally advanced colorectal cancer
BackgroundIn recent years, there has been significant research interest in immunotherapy for colorectal cancer (CRC). Specifically, immunotherapy has emerged as the primary treatme...
Combinatory Immunotherapy for Glioblastoma Treatment
Combinatory Immunotherapy for Glioblastoma Treatment
AbstractDespite advancements in the treatment of glioblastoma, it faces challenges due to tumor heterogeneity, the blood‐brain barrier, recurrence, immune evasion, and conventional...
PHARMACEUTICAL AND CLINICAL CHALLENGES OF BIOLOGICAL MEDICINES: ONGOING HURDLES FROM DRUG DEVELOPMENT TO THERAPEUTIC APPLICATIONS
PHARMACEUTICAL AND CLINICAL CHALLENGES OF BIOLOGICAL MEDICINES: ONGOING HURDLES FROM DRUG DEVELOPMENT TO THERAPEUTIC APPLICATIONS
Beyond conventional small drug molecules mostly of synthetic origin, clinical benefits have been well established by administering large complex biomolecules against different dise...

